Recent work tagged pharmaceuticals
Future Fields was founded to grow meat in the lab. It pivoted to generating the growth factor that cellular agriculture depends on. And now its leaders see a whole new opportunity in developing recombinant protein for therapeutics, vaccines, and other such applications.
The provincial government has committed $15.5 million in funding to Entos Pharmaceuticals to establish a new commercial manufacturing facility in Edmonton, which would produce vaccines as well as future genetic medicines. Now it's "a dance" to secure the rest of the funding needed.
Entos Pharmaceuticals has announced a new partnership with BioMarin Pharmaceutical Inc. to develop its gene therapy candidates using its Fusogenix platform
Alberta's world-class talent and expertise, as well as its biotechnology infrastructure, will help the sector thrive through COVID-19 and beyond, a panel said this week.